This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Feb;102(2):179-182.

doi: 10.1097/TP.0000000000002042.

Preserving Treg Function: Beyond mTOR Inhibitors

George Adigbli¹, Fadi Issa¹

Affiliations

PMID: 29319616
DOI: 10.1097/TP.0000000000002042

Comment

Preserving Treg Function: Beyond mTOR Inhibitors

George Adigbli et al. Transplantation. 2018 Feb.

. 2018 Feb;102(2):179-182.

doi: 10.1097/TP.0000000000002042.

Authors

George Adigbli¹, Fadi Issa¹

Affiliation

¹ Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, UK.

PMID: 29319616
DOI: 10.1097/TP.0000000000002042

No abstract available

PubMed Disclaimer

Comment on

Combined OX40L and mTOR blockade controls effector T cell activation while preserving T_reg reconstitution after transplant.
Tkachev V, Furlan SN, Watkins B, Hunt DJ, Zheng HB, Panoskaltsis-Mortari A, Betz K, Brown M, Schell JB, Zeleski K, Yu A, Kirby I, Cooley S, Miller JS, Blazar BR, Casson D, Bland-Ward P, Kean LS. Tkachev V, et al. Sci Transl Med. 2017 Sep 20;9(408):eaan3085. doi: 10.1126/scitranslmed.aan3085. Sci Transl Med. 2017. PMID: 28931653 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal